PRTN3 and rapidly progressive glomerulonephritis: CQ2: Is testing serum MPO-ANCA, PR3-ANCA and anti-GBM antibody levels recommended for a differential diagnosis of RPGN in patients showing urinary abnormalities and worsening renal function within a few weeks or a few months?